Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/12/2013 | CA2331765C Formaldehyde dehydrogenase genes from methylotrophic yeasts |
03/12/2013 | CA2295552C Cloned genomes of infectious hepatitis c viruses and uses thereof |
03/12/2013 | CA2288218C Novel differentiation-inhibitor |
03/08/2013 | CA2845395A1 Antibody against colorectal cancer marker |
03/07/2013 | WO2013033656A1 Methods for the treatment of breast cancer |
03/07/2013 | WO2013033652A1 Metabolic engineering of the shikimate pathway |
03/07/2013 | WO2013033646A1 In vivo conversion of light energy into hydrogen gas |
03/07/2013 | WO2013033626A2 Nkp30 receptor targeted therapeutics |
03/07/2013 | WO2013033611A1 Methods and compositions for watermelon firmness |
03/07/2013 | WO2013033604A2 Production of butanols in thermophilic organisms |
03/07/2013 | WO2013033571A1 Plants with enhanced tolerance to multiple abiotic stresses |
03/07/2013 | WO2013033369A2 Engineered plant biomass for biodiesel and bioethanol production |
03/07/2013 | WO2013033363A1 Mycobacterium tuberculosis porins and toxins and related methods |
03/07/2013 | WO2013033362A1 Yeast expression of flavivirus virus-like particles and use thereof |
03/07/2013 | WO2013033308A2 Methods for tissue culture and transformation of sugarcane |
03/07/2013 | WO2013033230A1 Oligomer-conjugate complexes and their use |
03/07/2013 | WO2013033223A1 Methods and compounds useful in conditions related to repeat expansion |
03/07/2013 | WO2013033094A2 Elimination of seed formation by ablating floral organs |
03/07/2013 | WO2013033069A1 Human rhinovirus (hrv) antibodies |
03/07/2013 | WO2013033019A1 Methods for determining the integrity of a biological sample |
03/07/2013 | WO2013032985A1 Transformation of juvenile and mature citrus |
03/07/2013 | WO2013032850A2 Compositions and methods for high fidelity assembly of nucleic acids |
03/07/2013 | WO2013032242A2 Target non-binding aptamer selection method using graphene and aptamer selected therefrom |
03/07/2013 | WO2013032210A2 Biomembrane permeable composition |
03/07/2013 | WO2013032174A2 Protein synthesis kit, and method for expressing and extracting proteins using automatic extraction equipment |
03/07/2013 | WO2013032028A1 New compound material, medicine containing same, and cancer treatment method using same |
03/07/2013 | WO2013031975A1 Method for producing intermediate for biosynthesis of fusicoccin a, and synthase for use in said method |
03/07/2013 | WO2013031973A1 Method for detecting toxin-producing clostridium difficile |
03/07/2013 | WO2013031956A1 NUCLEIC ACID CONSTRUCT INCLUDING NUCLEIC ACID DERIVED FROM GENOTYPE 3a HCV GENOME |
03/07/2013 | WO2013031931A1 Chemokine receptor activity regulator |
03/07/2013 | WO2013031912A1 Substrate and analysis method |
03/07/2013 | WO2013031882A1 Vaccine preparation for cancer treatment |
03/07/2013 | WO2013031853A1 Method for predicting prognosis of prostate cancer |
03/07/2013 | WO2013031821A1 Protein production method using transformed plant cells |
03/07/2013 | WO2013031734A1 Transgenic bird expressing foreign gene using endoplasmic reticulum chaperone promoter |
03/07/2013 | WO2013031704A1 Heptamer-type small guide nucleic acid capable of inducing apoptosis of human leukemia cell |
03/07/2013 | WO2013031700A1 Method for exclusive selection of circularized dna from monomolecular dna when circularizing dna molecules |
03/07/2013 | WO2013031664A1 Flavin-binding glucose dehydrogenase |
03/07/2013 | WO2013031619A1 Image-based tumor diagnosis agent containing anti-human transferrin receptor antibody |
03/07/2013 | WO2013031323A1 Anti-aging agent screening method and aging state evaluation method |
03/07/2013 | WO2013031322A1 Three-dimensional co-culture model and method for utilizing same |
03/07/2013 | WO2013030812A1 High-methionine transgenic soybean seeds expressing the arabidopsis cystathionine gamma-synthase gene |
03/07/2013 | WO2013030778A2 Organic compositions to treat hsf1-related diseases |
03/07/2013 | WO2013030569A2 Peptides |
03/07/2013 | WO2013030568A1 Caninised tumour necrosis factor antibodies and methods of using the same |
03/07/2013 | WO2013030362A1 Modulators of mir-323-3p for the prevention or treatment of rheumatoid arthritis |
03/07/2013 | WO2013030329A1 Protein expression |
03/07/2013 | WO2013030245A1 Optical based delivery of exogenous molecules to cells |
03/07/2013 | WO2013029919A1 Method and kit for the isolation of genomic dna, rna, proteins and metabolites from a single biological sample |
03/07/2013 | WO2013029800A1 Threonine synthase from nicotiana tabacum and methods and uses thereof |
03/07/2013 | WO2013029799A1 Isopropylmalate synthase from nicotiana tabacum and methods and uses thereof |
03/07/2013 | WO2013029496A1 Polypeptides having glucoamylase activity and polynucleotides encoding same |
03/07/2013 | WO2013029494A1 Polypeptides having glucoamylase activity and polynucleotides encoding same |
03/07/2013 | WO2013029205A1 Cleavable protein of interferon fused with human serum albumin and encoding gene and use thereof |
03/07/2013 | WO2013029176A1 Novel cellobiohydrolase enzymes |
03/07/2013 | WO2013029170A1 A process for producing cellulase mixtures from myceliophthora and related organisms |
03/07/2013 | WO2013010062A3 Nucleic acid complexity reduction |
03/07/2013 | WO2013004396A3 Adeno-parvovirus chimera with enhanced oncolytical potential |
03/07/2013 | WO2012170560A3 Microfluidic device for extracting, isolating, and analyzing dna from cells |
03/07/2013 | WO2012169819A3 Method for producing polyhydroxyalkanoate containing 2-hydroxybutyrate as the monomer |
03/07/2013 | WO2012169741A3 Fcεri-specific human antibody and composition comprising same for treating or diagnosing allergic diseases |
03/07/2013 | WO2012162049A3 Methods and compositions for measuring radiation exposure in a subject |
03/07/2013 | WO2012156839A9 Splice - less lentiviral vectors for safter gene therapy applications |
03/07/2013 | WO2012141445A3 Method for analyzing the risk of hepatoma onset for chronic patients of hepatitis type b, and method of predicting same |
03/07/2013 | WO2012135635A3 Ovarian cancer biomarkers |
03/07/2013 | WO2012116331A3 Methods and systems for haplotype determination |
03/07/2013 | WO2012106428A3 Detection methods for target dna |
03/07/2013 | WO2012096545A3 Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof |
03/07/2013 | US20130061354 Polypeptide having cellobiohydrolase activity and uses thereof |
03/07/2013 | US20130061353 Transgenic aloe plants for production of proteins and related methods |
03/07/2013 | US20130061351 Method for producing recombinant proteins from plant hairy roots |
03/07/2013 | US20130061350 Plants and seeds of common wheat cultivar wb-700 |
03/07/2013 | US20130061349 Transformation of Juvenile and Mature Citrus |
03/07/2013 | US20130061348 Nucleic Acid Sequences Encoding Proteins Associated with Abiotic Stress Responses and Plant Cells with Increased Tolerance to Environmental Stress |
03/07/2013 | US20130061345 Transcription regulators for improving plant performance |
03/07/2013 | US20130061343 In vivo gene regulation by the combination of knock-in-teto sequence into the genome and tetracycline-controlled trans-suppressor (tts) protein |
03/07/2013 | US20130061342 Identification and Enrichment of Cell Subpopulations |
03/07/2013 | US20130061341 Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof |
03/07/2013 | US20130060053 Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
03/07/2013 | US20130059931 Activation induced deaminase (aid) |
03/07/2013 | US20130059906 Methods and compositions for influencing tumors using microrna-185 as a tumor suppressor |
03/07/2013 | US20130059904 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
03/07/2013 | US20130059901 Pre-MRNA Trans-Splicing Molecule (RTM) Molecules and Their Uses |
03/07/2013 | US20130059825 Antibodies to 25-HYDROXY Vitamin D2 and D3 and Uses Thereof |
03/07/2013 | US20130059793 Egf receptor mimicking peptides |
03/07/2013 | US20130059785 Gene and Polypeptide Sequences |
03/07/2013 | US20130059780 Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
03/07/2013 | US20130059777 Modulation of glucose-6-phosphatase translocase expression |
03/07/2013 | US20130059763 System for photolithographic synthesis of polymer arrays |
03/07/2013 | US20130059760 siRNA Targeting Fructose-1, 6-bisphosphatase 1 (FBP1) |
03/07/2013 | US20130059757 Novel Gene Targets Associated with Amyotrophic Lateral Sclerosis and Methods of Use Thereof |
03/07/2013 | US20130059752 Compositions and methods for the treatment of immune related diseases |
03/07/2013 | US20130059732 Aav capsid proteins for nucleic acid transfer |
03/07/2013 | US20130059389 Method for Producing Kluyveromyces Marxianus Transformant |
03/07/2013 | US20130059388 Methods for generating endogenously tagged proteins |
03/07/2013 | US20130059387 Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof |
03/07/2013 | US20130059386 Induced pluripotent stem cells produced with oct3/4, klf and sox |
03/07/2013 | US20130059385 Methods of generating pluripotent stem cells |
03/07/2013 | US20130059374 Novel Therapeutical Tools and Methods for Treating Blindness |
03/07/2013 | US20130059363 Isolated Nucleic Acids for Producing High Viscosity Diutan Gums and Methods |